Laure Rolland

Lille, 59000, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications

IL-34 is expressed in the pancreas and regulates local inflammation.

IL-34 is expressed in the pancreas and regulates local inflammation.

Journal: Translational research : the journal of laboratory and clinical medicine
Published: January 18, 2024

High-Throughput Quantitative Screening of Glucose-Stimulated Insulin Secretion and Insulin Content Using Automated MALDI-TOF Mass Spectrometry.

High-Throughput Quantitative Screening of Glucose-Stimulated Insulin Secretion and Insulin Content Using Automated MALDI-TOF Mass Spectrometry.

Journal: Cells
Published: February 14, 2023

Pharmacological HDAC inhibition impairs pancreatic β-cell function through an epigenome-wide reprogramming.

Pharmacological HDAC inhibition impairs pancreatic β-cell function through an epigenome-wide reprogramming.

Journal: iScience
Published: February 02, 2023

β-Cell-Specific E2f1 Deficiency Impairs Glucose Homeostasis, β-Cell Identity, and Insulin Secretion.

β-Cell-Specific E2f1 Deficiency Impairs Glucose Homeostasis, β-Cell Identity, and Insulin Secretion.

Journal: Diabetes
Published: July 04, 2022

Impaired Glucose Homeostasis in a Tau Knock-In Mouse Model.

Impaired Glucose Homeostasis in a Tau Knock-In Mouse Model.

Journal: Frontiers in molecular neuroscience
Published: December 22, 2021

Glucose Regulates m6A Methylation of RNA in Pancreatic Islets.

Glucose Regulates m6A Methylation of RNA in Pancreatic Islets.

Journal: Cells
Published: September 19, 2021

The transcription factor E2F1 controls the GLP-1 receptor pathway in pancreatic β cells.

The transcription factor E2F1 controls the GLP-1 receptor pathway in pancreatic β cells.

Journal: Cell reports
Published: April 28, 2021

Increased Hepatic PDGF-AA Signaling Mediates Liver Insulin Resistance in Obesity-Associated Type 2 Diabetes.

Increased Hepatic PDGF-AA Signaling Mediates Liver Insulin Resistance in Obesity-Associated Type 2 Diabetes.

Journal: Diabetes
Published: December 18, 2017

Electrochemically triggered release of human insulin from an insulin-impregnated reduced graphene oxide modified electrode.

Electrochemically triggered release of human insulin from an insulin-impregnated reduced graphene oxide modified electrode.

Journal: Chemical communications (Cambridge, England)
Published: August 11, 2015

The class I histone deacetylase inhibitor MS-275 prevents pancreatic beta cell death induced by palmitate.

The class I histone deacetylase inhibitor MS-275 prevents pancreatic beta cell death induced by palmitate.

Journal: Journal of diabetes research
Published: August 28, 2014
Showing 1-10 of 10

Last Updated: 09/26/2026